Download the executive brief

Cancer facts

Over 40% of all men and women will be diagnosed with cancer at some point in their lifetime1.

Prescribed therapies don't always work well for a specific type of cancer and different treatment options are sometimes needed, but cancer patients have little time to waste on therapy changes2.

National health care costs associated with cancer treatment are expected to rise 34% to $246 billion in annual spend by 20303.

What is the Oncology Care Value Program?

The Oncology Care Value Program®, part of the SafeGuardRx® platform, has been supporting plans and patients for many years, aligning medication costs with their outcomes for various types of cancers while offering drug discounts and early discontinuation reimbursements to plan sponsors.

The program also ensures that members have access to personalized medicine—the right drug at the right time.

Member Benefits

Experienced support

New-to-therapy patients that are directed to a preferred drug, based on indication, receive clinician assistance and education through the Oncology Therapeutic Resource Center®.

Personalized guidance

Specialists provide expert clinical counseling to members to optimize care. Access to specialist pharmacists and nurses is free of charge to all members.

Lower costs

Cost savings on expensive oncology medications when filled at Accredo® Specialty Pharmacy.

Plan Benefits

Financial protection

Savings are realized with early discontinuation reimbursement for breast cancer and ovarian cancer patients who stop treatment early.

Fair pricing

Indication-based management aligns drug cost based on efficacy at the indication level, so you and your members are paying fair drug prices for guideline-driven therapy.

Frequently Asked Questions

  • What indications/drugs are included in the program?

    Evernorth® has been able work with manufacturers to secure exclusive added value for clients within this program. Below are the included indications:

    • Prostate Cancer
    • Renal Cell Carcinoma
    • Non-Small Cell Lung Cancer
    • Breast Cancer
    • Ovarian Cancer
    • Chronic Myeloid Leukemia
    • Basal Cell Carcinoma
    • Thyroid Cancer
  • How does the Oncology Care Value Program impact members?
    • Indication-based management aligns drug cost based on the efficacy at the indication level, so members are paying fair drug prices for guideline-driven therapy.
    • Cost savings on expensive oncology medications when filled at Accredo Specialty Pharmacy.
    • Specialized care from the Oncology Therapeutic Resource Center.
  • How does the Oncology Care Value Program benefit plans?

    With over 700 oncology drugs in the development pipeline, there is a need for an innovative solution to manage these costs while ensuring patients are treated with the right drug for their condition at the right price. The Oncology Care Value Program uses indication-based management to assist plans in controlling oncology trend and help patients get the right drug at the right price.

    When filled at Accredo, AWP discounts will be applied for participating oncology drugs. Additional cost savings are available in the form of early discontinuation reimbursements (either a flat dollar amount or a percentage off AWP, depending on drug) for new-to-therapy patients only. Program-specific requirements apply.

  1. National Cancer Institute. Cancer Stat Facts: Cancer of Any Site.
  2. American Society of Clinical Oncology. Journal of Clinical Oncology.
  3. American Association for Cancer Research. Newsroom.